Exciting New Drug - COG1410

Researchers have shown that a single dose of COG1410, a small molecule derived from the APOE receptor region of the brain, improves outcome following TBI. In these early animal tests, significant improvement was found after administration of this drug, speculating that the drug appears to block the development of significant behavioral deficits and reduces tissue loss associated with TBI.